165. [IF=3.8] Xu Wang et al."A HPLC-assisted mathematical prediction method of ternary solvent systems to develop an intelligent online selection system for countercurrent chromatography solvent system."JOURNAL OF CHROMATOGRAPHY A.2024 Dec;:465585 164. [IF=5.6] Jiake Wen et al."Green microextraction using deep eutectic solvents: Computer-aided analysis of bioactive components in natural products."INDUSTRIAL CROPS AND PRODUCTS.2025 Feb;224:120366 163. [IF=5.6] Yixuan Wang et al."Anti-melanogenesis activity and chemical profiling of herbaceous peony (Paeonia lactiflora Pall.) flowers: A natural skin whitening agents containing Paeonia monoterpene glycosides."INDUSTRIAL CROPS AND PRODUCTS.2025 Mar;225:120363 162. [IF=10.1] Wen Yang et al."Gut Microbiota, a Potential Mediated Target for Reducing Geniposide Hepatotoxicity by Interacting with Isoflavones."Engineering.2025 Feb;: 161. [IF=3.1] Xuanxuan Zhou et al."Exploration of material basis: Chemical composition profile and metabolic profile in Xiao Jianzhong Granules."JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS.2025 Aug;260:116793 160. [IF=1.1] Haojie ZHANG et al."Inhibitory effect of paeoniflorin on the LuxS/AI-2 quorum sensing system and the virulence of Glaesserella parasuis."JOURNAL OF VETERINARY MEDICAL SCIENCE. 159. [IF=8.7] Xintao Jia et al."Application of a novel thermal/pH-responsive antibacterial paeoniflorin hydrogel crosslinked with amino acids for accelerated diabetic foot ulcers healing."Materials Today Bio.2025 Jun;32:101736 158. [IF=4.7] Zhengyao Yu et al."Exploring the Therapeutic and Gut Microbiota-Modulating Effects of Qingreliangxuefang on IMQ-Induced Psoriasis."Drug Design Development and Therapy. 157. [IF=6.2] Mingxuan Song et al."Paeoniflorin alleviates toxicity and accumulation of 6-PPD quinone by activating ACS-22 in Caenorhabditis elegans."ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY.2024 Nov;286:117226 156. [IF=5.6] Rong Yuan et al."Tetramethylpyrazine and paeoniflorin combination (TMP-PF) alleviates atherosclerosis progress by reducing hyperlipemia and inhibiting plaque angiogenesis via the NR4A1/VEGFR2 pathway."Food Science and Human Wellness.2024 Sep;13:2642 155. [IF=4.5] Haigang Li et al."Enteric coating of halloysite nanotube/ o-butyrylated chitosan microspheres for the co-delivery of paeoniflorin and butyric acid to colon."JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY.2025 Feb;104:106508 154. [IF=2.1] Tianzhu Zhang et al."Introduced paeoniflorin reduces the main toxicity induced by diosbulbin B, the major toxic compound of Dioscorea bulbifera L.: involved inhibiting inflammation and ferroptosis."DRUG AND CHEMICAL TOXICOLOGY. 153. [IF=3.4] Gu Qifei et al."Microfluidic Approach for Enhanced Paeoniflorin Transdermal Delivery: A Comparative Study on Different Chips and Mixing Dynamics."AAPS PHARMSCITECH.2025 Jan;26(1):1-17 152. [IF=3.4] Suhong Chen et al."Metabolomics analyses reveal the liver-protective mechanism of Wang's metabolic formula on metabolic-associated fatty liver disease."Heliyon.2024 Jul;10:e33418 151. [IF=3.7] Mingxin Guo et al."Pharmacological Components and Mechanism Research on the Treatment of Myelosuppression after Chemotherapy with Danggui Jixueteng Decoction Based on Spectrum-Effect Relationships and Transcriptome Sequencing."ACS Omega.2024;9(26):28926–2 150. [IF=4.2] Mengzhen Ma et al."Integrating UPLC-Q-TOF-MS and Network Pharmacology to Explore the Potential Mechanisms of Paeonia lactiflora Pall. in the Treatment of Blood Stasis Syndrome."MOLECULES.2024 Jan;29(13):3019 149. [IF=2.8] Zhu Yuanying et al."New insight into the molecular mechanism of TCM Bufei Huoxue formula for chronic obstructive pulmonary disease based on network pharmacology and experimental verification."JOURNAL OF PHARMACY AND PHARMACOLOGY.2024 Aug;: 148. [IF=4.9] Huaming Xi et al."Paeoniflorin Promotes Ovarian Development in Mice by Activating Mitophagy and Preventing Oxidative Stress."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2024 Jan;25(15):8355 147. [IF=6.7] Yinhuang Gao et al."Buqi Huoxue Tongnao prescription protects against chronic cerebral hypoperfusion via regulating PI3K/AKT and LXRα/CYP7A1 signaling pathways."PHYTOMEDICINE.2024 Sep;132:155844 146. [IF=3.4] Cuicui Xu et al."LMD and LC-MS-based chemical constituents and pharmacological effects assessment for two different processing methods of the root of Paeonia lactiflora Pall.."JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS".2024 Aug;245:116184 145. [IF=5.4] Weiliang Fu et al."Network pharmacology combined with affinity ultrafiltration to elucidate the potential compounds of Shaoyao Gancao Fuzi Decoction for the treatment of rheumatoid arthritis."JOURNAL OF ETHNOPHARMACOLOGY".2024 Aug;330:118268 144. [IF=5.4] Sihao Zhang et al."Chang-Kang-Fang alleviates diarrhea predominant irritable bowel syndrome (IBS-D) through inhibiting TLR4/NF-κB/NLRP3 pathway."JOURNAL OF ETHNOPHARMACOLOGY".2024 Apr;:118236 143. [IF=5.4] Yang Wang et al."Buyang huanwu decoction promotes remyelination via miR-760-3p/GPR17 axis after intracerebral hemorrhage."JOURNAL OF ETHNOPHARMACOLOGY".2024 Jun;328:118126 142. [IF=7.9] Yuan Chen et al."Exploring the anti-skin inflammation substances and mechanism of Paeonia lactiflora Pall. Flower via network pharmacology-HPLC integration."PHYTOMEDICINE".2024 Jul;129:155565 141. [IF=7.9] Lili Su et al."Total paeony glycoside relieves neuroinflammation to exert antidepressant effect via the interplay between NLRP3 inflammasome, pyroptosis and autophagy."PHYTOMEDICINE".2024 Mar;:155519 140. [IF=3.4] Yanhua Jiang et al."Network pharmacology combined with lipidomics to reveal the regulatory effects and mechanisms of Kangzao granules in the hypothalamus of rats with central precocious puberty."JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS".2024 May; 139. [IF=5.4] Jialing Sun et al."Investigating the molecular mechanism of Qizhu anticancer prescription in inhibiting hepatocellular carcinoma based on high-resolution mass spectrometry and network pharmacology."JOURNAL OF ETHNOPHARMACOLOGY".2024 Feb;:117985 138. [IF=10] Congyan Liu et al."A Sustainable Retinal Drug Co-Delivery for Boosting Therapeutic Efficacy in wAMD: Unveiling Multifaceted Evidence and Synergistic Mechanisms."Advanced Healthcare Materials".2024 Mar;:2303659 137. [IF=7.9] Tian Lan et al."Paeoniflorin promotes PPARγ expression to suppress HSCs activation by inhibiting EZH2-mediated histone H3K27 trimethylation."PHYTOMEDICINE".2024 Jun;128:155477 136. [IF=3.4] Jiaxin Yin et al."Comprehensive multicomponent characterization and quality assessment of Xiaoyao Wan by UPLC-Q-Orbitrap-MS, HS-SPME-GC-MS and HS-GC-IMS."JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS.2024 Feb;239:115910 135. [IF=4.1] Liangliang He et al."A multi-module structure labelled molecular network orients the chemical profiles of traditional Chinese medicine prescriptions: Xiaoyao San, as an example."JOURNAL OF CHROMATOGRAPHY A.2024 Jan;1715:464613 134. [IF=5.4] Hui Ren et al."Integrated serum metabolomics and network pharmacology analysis on the bioactive metabolites and mechanism exploration of Bufei huoxue capsule on chronic obstructive pulmonary disease rats."JOURNAL OF ETHNOPHARMACOLOGY.2024 Apr;324:117816 133. [IF=5.4] Keyan Jiao et al."Glycosides of Buyang Huanwu decoction inhibits inflammation associated with cerebral ischemia-reperfusion via the PINK1/Parkin mitophagy pathway."JOURNAL OF ETHNOPHARMACOLOGY.2024 Jan;:117766 132. [IF=5.4] Yingqiu Shi et al."Effective constituents and protective effect of Mudan granules against Schwann cell injury."JOURNAL OF ETHNOPHARMACOLOGY.2024 Apr;323:117692 131. [IF=6] Qianqian Chen et al."Optimization of extraction process of Astragali radix-Paeoniae radix alba by comparing BBD-RSM and SA-BPNN and antioxidant activity."LWT-FOOD SCIENCE AND TECHNOLOGY.2024 Jan;191:115677 130. [IF=5.6] Lihong Ye et al."Si-Ni-San alleviates early life stress-induced depression-like behaviors in adolescence via modulating Rac1 activity and associated spine plasticity in the nucleus accumbens."Frontiers in Pharmacology.2023; 14: 1274121 129. [IF=5.4] Liangxin Zhao et al."UPLC-Q-Exactive/MS based analysis explore the correlation between components variations and anti-influenza virus effect of four quantified extracts of Chaihu Guizhi decoction."JOURNAL OF ETHNOPHARMACOLOGY.2023 Oct;:117318 128. [IF=5.4] Yi Lu et al."Efficacy and mechanism study of Baichanting compound, a combination of Acanthopanax senticosus (Rupr. and Maxim.) Harms, Paeonia lactiflora Pall and Uncaria rhynchophylla (Miq.) Miq. ex Havil, on Parkinson's disease based on metagenomics and m 127. [IF=4.3] Bao-Fei Yan et al."Huangqin decoction alleviates lipid metabolism disorders and insulin resistance in nonalcoholic fatty liver disease by triggering Sirt1/NF-κB pathway."WORLD JOURNAL OF GASTROENTEROLOGY.2023 Aug 21; 29(31): 4744–4762 126. [IF=6.7] Zhang Le et al."Paeoniflorin increases the survival of Pseudomonas aeruginosa infected Caenorhabditis elegans at the immunosuppression stage by activating PMK-1, BAR-1, and EGL-1 signals."ARCHIVES OF PHARMACAL RESEARCH.2023 Aug;:1-13 125. [IF=7.5] Meng Gao et al."Paeoniflorin inhibits hepatocellular carcinoma growth by reducing PD-L1 expression."BIOMEDICINE & PHARMACOTHERAPY.2023 Oct;166:115317 124. [IF=4.6] Fengge YANG et al."Deciphering chemical and metabolite profiling of Chang-Kang-Fang by UPLC-Q-TOF-MS/MS and its potential active components identification."Chinese Journal of Natural Medicines.2023 Jun;21:459 123. [IF=5.4] Yanhui Zhao et al."Danggui Shaoyao San: Chemical characterization and inhibition of oxidative stress and inflammation to treat CCl4-induced hepatic fibrosis."JOURNAL OF ETHNOPHARMACOLOGY.2023 Jul;:116870 122. [IF=5.7] Yang Liu et al."Paeoniflorin Coordinates Macrophage Polarization and Mitigates Liver Inflammation and Fibrogenesis by Targeting the NF-κB/HIF-1α Pathway in CCl4-Induced Liver Fibrosis."AMERICAN JOURNAL OF CHINESE MEDICINE. 121. [IF=4.81] Hu Shian et al."Shaoyao Gancao Decoction protects against dextran sulfate sodium-induced ulcerative colitis by down-regulating ferroptosis."JOURNAL OF PHARMACY AND PHARMACOLOGY.2023 May;: 120. [IF=5.195] YiNi Gao et al."Jiedu-Quyu-Ziyin Fang (JQZF) inhibits the proliferation and activation of B cells in MRL/lpr mice via modulating the AKT/mTOR/c-Myc signaling pathway."JOURNAL OF ETHNOPHARMACOLOGY.2023 Oct;315:116625 119. [IF=7.129] Kangchen Li et al."Uncovering mechanisms of Baojin Chenfei formula treatment for silicosis by inhibiting inflammation and fibrosis based on serum pharmacochemistry and network analysis."ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY.2023 Jul;260:115082 118. [IF=4.601] Guizhou Hu et al."Rapidly and accurately screening histidine decarboxylase inhibitors from Radix Paeoniae alba using ultrafiltration–high performance liquid chromatography/mass spectrometry combined with enzyme channel blocking and directional enrichment 117. [IF=4.885] Zijia Ma et al."Identification of potential angiotensin-I-converting enzyme inhibitory components in celery seed using UHPLC-MS and molecular docking."PROCESS BIOCHEMISTRY.2023 May;128:98 116. [IF=6.656] Lin Sun et al."Exploration of the anti-liver injury active components of Shaoyao Gancao decoction by network pharmacology and experiments in vivo."PHYTOMEDICINE.2023 Feb;:154717 115. [IF=10.753] Xin Hua et al."Paeoniflorin attenuates polystyrene nanoparticle-induced reduction in reproductive capacity and increase in germline apoptosis through suppressing DNA damage checkpoints in Caenorhabditis elegans."SCIENCE OF THE TOTAL ENVIRONMENT.2023 May;8 114. [IF=3.195] Yan, Fanchen et al."Glycoside combinations of Buyang Huanwu decoction ameliorate atherosclerosis via STAT3, HIF-1, and VEGF."NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY.2023 Jan;:1-17 113. [IF=4.927] Rong Yuan et al."Identification of a Novel Angiogenesis Signalling circSCRG1/miR-1268b/NR4A1 Pathway in Atherosclerosis and the Regulatory Effects of TMP-PF In Vitro."MOLECULES.2023 Jan;28(3):1271 112. [IF=5.572] Lin Peng et al."Identification and hepatoprotective activity of total glycosides of paeony with high content of paeoniflorin extracted from Paeonia lactiflora Pall."FOOD AND CHEMICAL TOXICOLOGY.2023 Mar;173:113624 111. [IF=5.195] Bao-Fei Yan et al."Huangqin decoction mitigates hepatic inflammation in high-fat diet-challenged rats by inhibiting TLR4/NF-κB/NLRP3 pathway."JOURNAL OF ETHNOPHARMACOLOGY.2023 Mar;303:115999 110. [IF=6.449] Xiaoxiao Wang et al."Physicochemical analysis, sensorial evaluation, astringent component identification and aroma-active compounds of herbaceous Peony (Paeonia lactiflora Pall) black tea."INDUSTRIAL CROPS AND PRODUCTS.2023 Mar;193:116159 109. [IF=4.927] Qinhua Zheng et al."Protective Effect of Flavonoids from Mulberry Leaf on AAPH-Induced Oxidative Damage in Sheep Erythrocytes."MOLECULES.2022 Jan;27(21):7625 108. [IF=5.195] Fang-Yuan Gao et al."Gut microbiota mediates the pharmacokinetics of Zhi-zi-chi decoction for the personalized treatment of depression."JOURNAL OF ETHNOPHARMACOLOGY.2023 Feb;302:115934 107. [IF=2.65] Bin Wang et al."Xiaoqinglong Decoction Enhances Autophagy to Antagonist Airway Inflammation Induced by Cold in Asthmatic Rats."Evidence-based Complementary and Alternative Medicine.2022 Oct 25;2022:3943343 106. [IF=5.195] Lijun Du et al."Jieduquyuziyin prescription promotes the efficacy of prednisone via upregulating Nrf2 in MRL/lpr kidneys."JOURNAL OF ETHNOPHARMACOLOGY.2022 Nov;298:115643 105. [IF=6.656] Di Deng et al."Sinisan alleviates depression-like behaviors by regulating mitochondrial function and synaptic plasticity in maternal separation rats."PHYTOMEDICINE.2022 Aug;:154395 104. [IF=6.656] Xinying Fu et al."Glycosides from Buyang Huanwu Decoction inhibit atherosclerotic inflammation via JAK/STAT signaling pathway."PHYTOMEDICINE.2022 Oct;105:154385 103. [IF=3.614] Jing Liu et al."Phytochemical identification of Xiaoer Huanglong Granule and pharmacokinetic study in the rat using its seven major bioactive components."JOURNAL OF SEPARATION SCIENCE 102. [IF=4.601] Menghan Chen et al."Rapid screening of neuraminidase inhibitors with the benzoic acid skeleton from Paeonia suffruticosa Andrews by solid-phase extraction with an enzyme activity switch combined with mass spectrometry analysis."JOURNAL OF CHROMATOGRAPHY A 101. [IF=5.195] Zehua Jin et al."Network pharmacology study to reveal active compounds of Qinggan Yin formula against pulmonary inflammation by inhibiting MAPK activation."JOURNAL OF ETHNOPHARMACOLOGY.2022 Oct;296:115513 100. [IF=6.576] Jia-Quan Liang et al."Paeoniflorin Rescued MK-801-Induced Schizophrenia–Like Behaviors in Mice via Oxidative Stress Pathway."Frontiers in Nutrition. 2022; 9: 870032 99. [IF=4.932] Wen-Jie Li et al."Effect of paeoniflorin on distal survival of random flaps."Int Immunopharmacol. 2022 Apr;105:108562 98. [IF=1.902] Jia Wang et al."Investigate the effect of honey on the absorption of seven active ingredients from wu-tou decoction in rats."Biomedical Chromatography. 2022 Jan 06 97. [IF=6.529] Ting Shang et al."The combination of four main components in Xuebijing injection improved the preventive effects of Cyclosporin A in acute graft-versus-host disease mice by protecting intestinal microenvironment."Biomed Pharmacother. 2022 Apr;148:112675 96. [IF=1.902] Chenxi Wang et al."Multiple component-pharmacokinetic studies on 10 bioactive constituents of Peiyuan Tongnao capsule using parallel reaction monitoring mode."Biomed Chromatogr. 2021 Oct;35(10):e5153 95. [IF=1.902] Ting Zhang et al."The influence of essential oils from ZhaLi NuSi Prescription on the pharmacokinetics of its non-volatile components in normal rats."Biomedical Chromatography. 2021 Oct 21 94. [IF=3.69] Qianni Duan et al."Antiviral effect of Chinese herbal prescription JieZe-1 on adhesion and penetration of VK2/E6E7 with herpes simplex viruses type 2."J Ethnopharmacol. 2020 Mar;249:112405 93. [IF=3.981] Haigang Li et al."Eudragit S100-coated halloysite nanotube/chitosan microspheres for colon-targeted release of paeoniflorin."J Drug Deliv Sci Tec. 2021 Feb;61:102258 92. [IF=4.142] Wang Chenxi et al."Systematic quality evaluation of Peiyuan Tongnao capsule by offline two-dimensional liquid chromatography/quadrupole-Orbitrap mass spectrometry and adjusted parallel reaction monitoring of quality markers."Anal Bioanal Chem. 2019 Nov;4 91. [IF=4.142] Hu Guizhou et al."An integrated strategy for the identification and screening of anti-allergy components from natural products based on calcium fluctuations and cell extraction coupled with HPLC–Q–TOF–MS."Anal Bioanal Chem. 2021 Oct;413(25):6253-6266 90. [IF=4.225] Ji Lina et al."Jieduquyuziyin Prescription Suppresses Inflammatory Activity of MRL/lpr Mice and Their Bone Marrow-Derived Macrophages via Inhibiting Expression of IRAK1-NF-κB Signaling Pathway."Front Pharmacol. 2020 Jul;0:1049 89. [IF=4.225] Shang Ting et al."Xuebijing Injection Maintains GRP78 Expression to Prevent Candida albicans–Induced Epithelial Death in the Kidney."Front Pharmacol. 2020 Jan;0:1416 88. [IF=4.36] Xiaoli Zhao et al."Transcriptomic study of the mechanism by which the Kai Yu Zhong Yu recipe improves oocyte quality in a stressed mouse model."J Ethnopharmacol. 2021 Oct;278:114298 87. [IF=4.36] Li-Mei Feng et al."An integrated strategy for discovering effective components of Shaoyao Gancao decoction for treating neuropathic pain by the combination of partial least-squares regression and multi-index comprehensive method."J Ethnopharmacol. 2020 Oc 86. [IF=4.36] Qiyang Shou et al."Total glucosides of peony improve ovalbumin-induced allergic asthma by inhibiting mast cell degranulation."J Ethnopharmacol. 2019 Nov;244:112136 85. [IF=4.769] Ruirui Chang et al."Isoflavones' effects on pharmacokinetic profiles of main iridoids from Gardeniae Fructus in rats."J Pharm Anal. 2020 Dec;10:571 84. [IF=5.076] Zhang Zepeng et al."Shen-Hong-Tong-Luo Formula Attenuates Macrophage Inflammation and Lipid Accumulation through the Activation of the PPAR-γ/LXR-α/ABCA1 Pathway."Oxid Med Cell Longev. 2020;2020:3426925 83. [IF=5.34] Jing Zhang et al."Application of “spider-web” mode in discovery and identification of Q-markers from Xuefu Zhuyu capsule."Phytomedicine. 2020 Oct;77:153273 82. [IF=5.34] Wendi Yu et al."Effect of paeoniflorin on acute lung injury induced by influenza A virus in mice. Evidences of its mechanism of action."Phytomedicine. 2021 Nov;92:153724 81. [IF=5.455] Dou Yinghuan et al."Preparation, optimization and in vitro–in vivo evaluation of Shunxin sustained release granules."Chin Med-Uk. 2019 Dec;14(1):1-10 80. [IF=5.645] Zhang-Zhen Bai et al."Comparative investigation on metabolites and biological activities of Paeonia ostii stamens from different geographical regions of China."Ind Crop Prod. 2021 Nov;172:114038 79. [IF=6.529] Yan He et al."Pharmacokinetics and biotransformation investigation in beagle dog of active compounds from naoxintong capsule."Biomed Pharmacother. 2021 Jan;133:110940 78. [IF=1.902] Xiujun Wu et al."Simultaneous determination of ginsenoside Rb1, ginsenoside Rg1, paeoniflorin, albiflorin and oxypaeoniflorin in rat plasma by liquid chromatography–tandem mass spectrometry: Application to a pharmacokinetic study of wen-Yang-Huo-Xue soft 77. [IF=1.984] Yuan Rong et al."Tetramethylpyrazine and Paeoniflorin Inhibit Oxidized LDL-Induced Angiogenesis in Human Umbilical Vein Endothelial Cells via VEGF and Notch Pathways."Evid-Based Compl Alt. 2018;2018:3082507 76. [IF=2.276] Song Chunhong et al."Paeoniflorin, the Main Active Ingredient of Shuyu Capsule, Inhibits Cav1.2 and Regulates Calmodulin/Calmodulin-Dependent Protein Kinase II Signalling."Biomed Res Int. 2017;2017:8459287 75. [IF=3.205] Dong-Dong Hu et al."Simultaneous determination of ten compounds in rat plasma by UPLC-MS/MS: Application in the pharmacokinetic study of Ma-Zi-Ren-Wan."J Chromatogr B. 2015 Sep;1000:136 74. [IF=3.212] Li Huan et al."Paeoniflorin Ameliorates Atherosclerosis by Suppressing TLR4-Mediated NF-κB Activation."Inflammation. 2017 Dec;40(6):2042-2051 73. [IF=3.922] Wei Wang et al."Peony-Glycyrrhiza Decoction, an Herbal Preparation, Inhibits Clozapine Metabolism via Cytochrome P450s, but Not Flavin-Containing Monooxygenase in In Vitro Models."Drug Metab Dispos. 2015 Jul;43(7):1147-1153 72. Li-Mei Feng, Yan-Yan Chen, Ding-Qiao Xu, Rui-Jia Fu, Shi-Jun Yue, Qi Zhao, Yu-Xi Huang, Xue Bai, Mei Wang, Li-Ming Xing, Yu-Ping Tang, Jin-Ao Duan, An integrated strategy for discovering effective components of Shaoyao Gancao decoction for treating neuropa 71. Li-Mei Feng, Yan-Yan Chen, Ding-Qiao Xu, Rui-Jia Fu, Shi-Jun Yue, Qi Zhao, Yu-Xi Huang, Xue Bai, Mei Wang, Li-Ming Xing, Yu-Ping Tang, Jin-Ao Duan, An integrated strategy for discovering effective components of Shaoyao Gancao decoction for treating neuropa 70. Duan, Qianni, et al. "Antiviral effect of Chinese herbal prescription JieZe-1 on adhesion and penetration of VK2/E6E7 with herpes simplex viruses type 2." Journal of ethnopharmacology 249 (2020): 112405.https://doi.org/10.1016/j.jep.2019.112405 69. Li, H., Jiao, Y. & Xie, M. Paeoniflorin Ameliorates Atherosclerosis by Suppressing TLR4-Mediated NF-κB Activation. Inflammation 40, 2042–2051 (2017). https://doi.org/10.1007/s10753-017-0644-z 68. Chunhong Song, Jieqiong Wang, Dongmei Gao, Yanhong Yu, Fang Li, Sheng Wei, Peng Sun, Meiyan Wang, Mingqi Qiao, "Paeoniflorin, the Main Active Ingredient of Shuyu Capsule, Inhibits Cav1.2 and Regulates Calmodulin/Calmodulin-Dependent Protein Kinase II Signa 67. Wei Wang, Dan-Dan Tian, Bin Zheng, Di Wang, Qing-Rong Tan, Chuan-Yue Wang and Zhang-Jin Zhang Drug Metabolism and Disposition July 2015, 43 (7) 1147-1153; DOI: https://doi.org/10.1124/dmd.114.062653 66. 徐超,林杰,金傳山,劉軍玲.HPLC指紋圖譜結(jié)合化學(xué)計(jì)量學(xué)比較同株不同生長(zhǎng)年限亳白芍化學(xué)成分差異[J].中草藥,2021,52(08):2408-2413. 65. 薛夢(mèng)潔,于卉娟,王璐瑤,柴欣,楊靜,王躍飛.血府逐瘀湯提取過(guò)程中成分的量變規(guī)律研究[J].天津中醫(yī)藥,2021,38(01):109-112. 64. 趙秋龍,卞曉坤,錢大瑋,宿樹蘭,郭盛,王團(tuán)結(jié),段金廒.桂枝茯苓膠囊在原發(fā)性痛經(jīng)模型大鼠血漿、膽汁、尿液和糞便中的代謝產(chǎn)物研究[J].藥物分析雜志,2021,41(01):51-63. 63. 宋晨鴿,陳天朝,馬彥江,王嬌,賈晴晴,李瑞穎,位玉蝶.基于酒醋鹽炙法探討赤芍不同炮制品飲片-丸劑物性參數(shù)與化學(xué)成分的相關(guān)性[J].中國(guó)現(xiàn)代應(yīng)用藥學(xué),2021,38(05):548-554. 62. 陳天朝,李沁,姚超,耿夢(mèng)麗,于蘭蘭,王嬌,馬彥江.赤芍不同炮制品及標(biāo)準(zhǔn)湯劑的物性參數(shù)及主要成分、指標(biāo)成分含量的研究[J].中華中醫(yī)藥學(xué)刊,2021,39(02):113-117. 61. 延霞,涂豐霞,林則彬.芍藥苷對(duì)缺氧缺血性腦損傷新生大鼠認(rèn)知功能的影響[J].中國(guó)臨床藥理學(xué)雜志,2020,36(24):3992-3994. 60. 段昆,高霞,耿婷,陳夏霖,曹亮,肖偉,王振中.基于血清代謝組學(xué)技術(shù)探討桂枝茯苓膠囊及其主要成分治療原發(fā)性痛經(jīng)的作用機(jī)制[J].中國(guó)新藥雜志,2020,29(18):2066-2074. 59. 劉秋艷,段佩利,張海波,金燕飛.響應(yīng)面法優(yōu)化骨瘤康顆粒提取工藝[J].遼寧中醫(yī)雜志,2021,48(03):142-145+225. 58. 李壯壯, 張靜, 趙紹哲,等. 指紋圖譜與化學(xué)計(jì)量學(xué)結(jié)合優(yōu)選柴胡桂枝顆粒水提工藝[J]. 中成藥, 2018, v.40(08):199-203. 57. 程江雪, 唐志書, 郭東艷, et al. 不同配伍配比對(duì)赤芍-當(dāng)歸藥對(duì)中10個(gè)成分溶出量的影響研究[J]. 藥物分析雜志, 2019, v.39(09):73-80. 56. 羅磊, 關(guān)寧寧, 向進(jìn)樂(lè),等. 牡丹花蕊醇提物對(duì)H_2O_2誘導(dǎo)HUVEC細(xì)胞損傷的保護(hù)作用[J]. 食品與機(jī)械, 2019, v.35;No.216(10):103-108. 55. 楊春梅 曹唯儀 侯俊玲 等. 丹酚酸B、芍藥苷和甘草酸復(fù)配在大鼠體內(nèi)的藥動(dòng)學(xué)參數(shù)研究[J]. 西北藥學(xué)雜志 2018 33(03):94-99. 54. 楊春梅 曹唯儀 林珈好 等. SPG復(fù)方主要成分配伍給藥在大鼠體內(nèi)藥動(dòng)學(xué)參數(shù)研究[J]. 遼寧中醫(yī)藥大學(xué)學(xué)報(bào) 2018 020(010):32-35. 53. 黃趙剛, 程鋼, 湯浩,等. 血必凈注射液指紋圖譜研究[J]. 中國(guó)醫(yī)院藥學(xué)雜志, 2018, 038(022):2323-2327. 52. 張靜 李壯壯 杜寶香 等. HPLC法同時(shí)測(cè)定柴胡桂枝湯中6種成分[J]. 中成藥 2018 040(010):2202-2205. 51. 趙園園,梁德勤,金傳山,魏慶紅,張偉,許鳳清,王林.基于HPLC指紋圖譜的亳白芍不同炮制品標(biāo)準(zhǔn)湯劑7個(gè)成分含量測(cè)定[J].天然產(chǎn)物研究與開發(fā),2018,30(03):404-411+500. 50. 付士朋, 沈宏偉, 王謙博,等. 赤芍飲片加工工藝的優(yōu)化[J]. 中成藥, 2019(8). 49. 鄭梅, 劉富壘, 薛敬偉,等. 基于肝微粒體和指紋圖譜研究六味地黃丸與硝苯地平的藥物相互作用[J]. 中國(guó)藥科大學(xué)學(xué)報(bào), 2018, 49(02):70-76. 48. 白一丹 喬洲 薛敬偉 等. 參松養(yǎng)心膠囊多組分同時(shí)測(cè)定及方法學(xué)驗(yàn)證[J]. 藥物分析雜志 2018 v.38(08):80-90. 47. 呂丹丹 何佳 宋文華 等. 8種乳酸菌發(fā)酵對(duì)鳳丹花瓣中酚類物質(zhì)及 其抗氧化活性的影響[J]. 食品與機(jī)械 2018 34(11):146-151. 46. 林紫微, 楊菲, 黃天一,等. 芍藥苷干預(yù)成骨細(xì)胞凋亡抗骨質(zhì)疏松作用研究[J]. 南京中醫(yī)藥大學(xué)學(xué)報(bào), 2019, 035(004):426-431. 45. 譚佳威, 杜守穎, 白潔,等. 白芍藥材的質(zhì)量屬性研究及產(chǎn)地評(píng)價(jià)[J]. 天津中醫(yī)藥, 2019, 036(005):504-510. 44. 王秀秀, 李智慧, 石森林,等. 桂枝茯苓濃縮丸多指標(biāo)成分體外溶出度研究[J]. 中華中醫(yī)藥學(xué)刊, 2014, 032(012):2875-2877. 43. 吳素香, 石森林, 葛衛(wèi)紅,等. 桂枝茯苓丸有效成分與物質(zhì)組的溶出相關(guān)性[J]. 中成藥, 2016, 38(11):2360-2365. 42. 付士朋, 沈宏偉, 王謙博,等. 指紋圖譜結(jié)合灰色關(guān)聯(lián)度分析法對(duì)不同產(chǎn)地赤芍質(zhì)量的評(píng)價(jià)研究[J]. 中草藥 2019年50卷23期, 5865-5871頁(yè), ISTIC PKU CSCD CA, 2019. 41. 余歡歡, 黃啟迪, 顏美秋,等. 孕康口服液3種成分測(cè)定及HPLC指紋圖譜建立[J]. 中成藥, 2020, v.42(03):46-51. 40. 趙秋龍,卞曉坤,錢大瑋,張婷,朱振華,郭盛,嚴(yán)輝,王團(tuán)結(jié),陳志鵬,段金廒.基于UPLC指紋圖譜及化學(xué)計(jì)量學(xué)的不同產(chǎn)地白芍差異比較研究[J].中國(guó)中藥雜志,2019,44(15):3316-3322. 39. 劉阿靜 齊廣才 劉珍葉 等. RP—HPLC法測(cè)定防風(fēng)通圣丸中芍藥苷 梔子苷 黃芩苷和連翹苷的含量[J]. 西北藥學(xué)雜志 2012 27(5):415-415. 38. 張嘉嘉 馬遲 朱志靈 張松柏 張勛.HPLC法同時(shí)測(cè)定白芍中5種成分含量[J].福建中醫(yī)藥 2019 50(01):66-67+70. 37. 王麗萍 張懷亮. HPLC同步測(cè)定天麻熄風(fēng)顆粒中6種成分的含量[J]. 醫(yī)藥論壇雜志 2018 v.39(06):20-23. 36. 劉瑾 林淵 王文靜. HPLC同時(shí)測(cè)定當(dāng)歸芍藥固體湯劑中芍藥苷 阿魏酸含量[J]. 廣東化工 2018 045(021):96-97 91. 35. 梁德勤, 趙園園, 羅云,等. 不同加工方式亳白芍的高效液相指紋圖譜及多成分含量比較[J]. 安徽中醫(yī)藥大學(xué)學(xué)報(bào), 2018. 34. 王化, 何丹嬈, 朱良玉,等. HPLC法同時(shí)測(cè)定赤芍中9個(gè)活性成分的含量[J]. 中草藥, 2018, 049(003):708-711. 33. 朱俊平 魏佳明 劉瑞連 等. 養(yǎng)精種玉湯的"點(diǎn)-線-面"質(zhì)量標(biāo)準(zhǔn)分析[J]. 中國(guó)實(shí)驗(yàn)方劑學(xué)雜志 2019(21):12-18. 32. 陳凱麗, 易劍峰, 孫蘭,等. 雷公藤多苷對(duì)白芍總苷在正常大鼠體內(nèi)藥代動(dòng)力學(xué)的影響[J]. 井岡山大學(xué)自然版, 2017(1). 31. 鄒龍, 李歡歡, 劉輝,等. 補(bǔ)陽(yáng)還五湯總苷膠囊的制備工藝優(yōu)選. 中國(guó)實(shí)驗(yàn)方劑學(xué)雜志. 30. 郭詩(shī)琦, 南敏倫, 赫玉芳,等. 藍(lán)莓酒肝清膠囊的制備工藝研究[J]. 食品研究與開發(fā), 2017(23):110-114. 29. 繆成貴, 熊友誼, 秦梅頌,等. 芍藥苷抑制佐劑性關(guān)節(jié)炎大鼠mTOR信號(hào)通路的實(shí)驗(yàn)研究[J]. 四川大學(xué)學(xué)報(bào)(醫(yī)學(xué)版), 2018(4). 28. 繆成貴,周麗麗,熊友誼,魏偉,陳兵兵,常俊.芍藥苷抑制佐劑性關(guān)節(jié)炎大鼠FLS異常增殖[J].中國(guó)免疫學(xué)雜志,2018,34(12):1809-1813. 27. 張丹, 趙軍, 孫鳳江,等. 芍藥苷對(duì)慢性高眼壓大鼠RGCs保護(hù)作用的研究[J]. 中國(guó)中醫(yī)眼科雜志, 2020, 030(004):239-243. 26. 何一博, 南麗紅, 黃枚,等. 芍藥苷對(duì)OGD海馬腦片中NLRP3炎癥小體介導(dǎo)細(xì)胞凋亡的影響[J]. 福建中醫(yī)藥, 2016, 047(002):25-28. 25. 郭春燕,羅強(qiáng),孫黎,張丹參,張紀(jì)平.芍藥苷對(duì)H_2O_2誘導(dǎo)SH-SY5Y神經(jīng)細(xì)胞損傷的保護(hù)作用[J].中草藥,2013,44(20):2864-2871. 24. 曾嘉豪. 芍藥苷對(duì)APP/PS1小鼠的神經(jīng)細(xì)胞保護(hù)作用及機(jī)制研究[D]. 暨南大學(xué), 2018. 23. 史素影, 俞年軍, 彭代銀,等. 芍藥根不同部位特征圖譜研究[J]. 云南中醫(yī)學(xué)院學(xué)報(bào) 2020年43卷1期, 12-18頁(yè), ISTIC, 2020. 22. 黃一鶴, 趙旻, 李一白,等. 膽胰康泰散的HPLC指紋圖譜研究[J]. 沈陽(yáng)藥科大學(xué)學(xué)報(bào), 2018, v.35；No.268(05):73-78. 21. 李博文,邱智東,董雪蓮.緩解體力疲勞保健食品桂芍舒逸口服液指紋圖譜研究[J].食品安全質(zhì)量檢測(cè)學(xué)報(bào),2019,10(07):2007-2011. 20. 李冬云, 曹秀蓮, 任艷青,等. 白芍水煎液中固體微粒對(duì)白芍總苷腸吸收的調(diào)節(jié)作用研究[J]. 河北中醫(yī)藥學(xué)報(bào), 2018(2):26-29. 19. 佘守軍, 鄭如程, 羅琴,等. 正交試驗(yàn)優(yōu)化鳳丹皮中單萜苷的煎煮工藝[J]. 湖北醫(yī)藥學(xué)院學(xué)報(bào), 2019, 38(02):140-142. 18. 段昆, 高霞, 耿婷, et al. 桂枝茯苓膠囊及其主要成分對(duì)原發(fā)性痛經(jīng)模型大鼠腸道菌群的影響[J]. 中國(guó)藥房, 2020, v.31;No.677(11):45-51. 17. 王立民, 呂品, 于志民,等. 施用有機(jī)物料對(duì)栽培赤芍土壤養(yǎng)分及品質(zhì)的影響[J]. 腐植酸, 2018, 185(06):41-46. 16. 劉明, 王慧森, 葛文靜,等. 多指標(biāo)正交試驗(yàn)法優(yōu)選春花降壓片水煎煮工藝[J]. 中醫(yī)藥導(dǎo)報(bào), 2020, v.26;No.350(04):20-22+27. 15. 牛曉靜, 曹英杰, 段曉穎. 多指標(biāo)正交試驗(yàn)優(yōu)選通絡(luò)調(diào)脂膠囊提取工藝[J]. 中藥新藥與臨床藥理, 2015, 026(006):851-854. 14. 張婕,梁程程,楊愛(ài)仲,齊聰.增免抑瘤方及有效組分對(duì)卵巢癌干細(xì)胞裸鼠移植瘤Notch/Jagged1信號(hào)通路的影響[J].中國(guó)實(shí)驗(yàn)方劑學(xué)雜志,2020,26(15):46-53. 13. 楊佩芬, 吳慶光, 劉四軍,等. 基于IGF-1R/Akt/PGC-1α通路探討芍藥苷對(duì)H2O2誘導(dǎo)PC12細(xì)胞氧化損傷的保護(hù)作用[J]. 中藥新藥與臨床藥理, 2019, 030(009):1055-1061. 12. 佚名. 基于2種分析方法的補(bǔ)陽(yáng)還五湯中有效成分提取工藝優(yōu)化研究[J]. 中草藥, 2018, 01(v.49;No.612):140-146. 11. 張春婷 邱智東 李博文 等. 保健食品桂芍舒逸口服液的工藝優(yōu)選與質(zhì)量標(biāo)準(zhǔn)建立[J]. 食品安全質(zhì)量檢測(cè)學(xué)報(bào) 2019 010(018):6316-6321. 10. 佘守軍 鄭如程 代算算 等. 不同方法提取亳州牡丹皮中3種單萜苷的比較研究[J]. 宜春學(xué)院學(xué)報(bào) 2019(9):32-36. 9. 閆冉 李智慧 石森林 等. 不同廠家桂枝茯苓丸在不同溶出介質(zhì)中的多條溶出曲線比較[J]. 中華中醫(yī)藥雜志 2016(3):1044-1048. 8. 張佳歡 李智慧 石森林 等. 不同劑型桂枝茯苓丸的溶出度比較[J]. 浙江中醫(yī)雜志 2019 v.54;No.582(09):73-74. 7. 于現(xiàn)花 高海燕 金傳山 等. 不同產(chǎn)地白芍標(biāo)準(zhǔn)煎液的指紋圖譜及4種單萜苷類成分含量測(cè)定[J]. 中國(guó)現(xiàn)代應(yīng)用藥學(xué) 2020(11):1290-1295. 6. 鄒龍 劉輝 李仲秋 等. HPLC測(cè)定補(bǔ)陽(yáng)還五湯總苷中黃芪甲苷和芍藥苷的含量[J]. 湖南中醫(yī)藥大學(xué)學(xué)報(bào) 2012 32(005):39-42. 5. 李智慧 吳素香 石森林 等. HPLC測(cè)定不同廠家桂枝茯苓丸中丹皮酚及芍藥苷[J]. 中國(guó)實(shí)驗(yàn)方劑學(xué)雜志 2013 19(009):121-123. 4. 邵建兵 汪燕. HPLC法同時(shí)測(cè)定固本益腸膠囊中5種成分[J]. 中成藥 2018 040(011):2446-2449. 3. 趙婷秀 曹迪 茆文莉 等. HPLC-QTOF-MS分析六味地黃丸不同部位的化學(xué)成分[J]. 中藥新藥與臨床藥理 2018 029(004):489-496. 2. 魏穎 王東超 高佳琪 秦靈靈 孫文 張巖 石浩霞 蘭衛(wèi) 徐暾海 劉銅華.HPLC-DAD法同時(shí)測(cè)定糖痹康中6種主要活性成分[J].長(zhǎng)春中醫(yī)藥大學(xué)學(xué)報(bào) 2016 32(06):1135-1138. 1. 佘守軍 鄭如程 陳蕾 等. Box-Behnken響應(yīng)面法優(yōu)選鳳丹皮中苷類成分的醇提工藝[J]. 陜西中醫(yī)藥大學(xué)學(xué)報(bào) 2019 042(004):21-27.